HeartSciences (HSCS) Non-Current Assets (2022 - 2025)

HeartSciences' (HSCS) quarterly Non-Current Assets came in at $2.1 million in Q4 2025, down 6.86% on a QoQ basis from $2.2 million in Q4 2025.

HeartSciences (HSCS) Non-Current Assets (2022 - 2025) Analysis & Trends

HeartSciences (HSCS) has 4 years of Non-Current Assets data on file, last reported at $2.1 million in Q4 2025.

Quarterly Non-Current Assets changed N/A year-over-year to $2.1 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $8.3 million (changed N/A YoY) and the FY2025 annual result came in at $2.1 million, down 4.55% from the prior year.
Non-Current Assets slipped to $2.1 million in Q4 2025, from $2.2 million in the prior quarter.
In the past five years, Non-Current Assets ranged from a high of $2.2 million in Q4 2025 to a low of $130793.0 in Q3 2022.
A 4-year average of $1.4 million and a median of $2.0 million in 2025 frame the typical range for Non-Current Assets.
The widest YoY moves for Non-Current Assets: up 334.83% in 2023, down 13.6% in 2023.
Tracing HSCS's Non-Current Assets over 4 years: stood at $643706.0 in 2022, then slipped by 13.6% to $556147.0 in 2023, then jumped by 275.47% to $2.1 million in 2024, then declined by 1.76% to $2.1 million in 2025.
The last three Non-Current Assets figures came in at $2.1 million (Q4 2025), $2.2 million (Q4 2025), and $2.0 million (Q3 2025), per Business Quant data.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Non-Current Assets (Qtr)
1	Abbott Laboratories	202.72 Bn	197.12 Bn	7.27 Bn	84.70 Bn
2	Stryker	126.42 Bn	122.94 Bn	4.50 Bn	33.51 Bn
3	Medtronic	119.75 Bn	110.53 Bn	6.41 Bn	68.24 Bn
4	Boston Scientific	74.13 Bn	73.60 Bn	3.85 Bn	37.24 Bn
5	Edwards Lifesciences	51.78 Bn	47.53 Bn	1.35 Bn	7.05 Bn
6	Dexcom	35.29 Bn	33.34 Bn	830.00 Mn	2.37 Bn
7	GE HealthCare Technologies	33.95 Bn	31.85 Bn	2.18 Bn	26.75 Bn
8	Koninklijke Philips	26.22 Bn	22.90 Bn	4.55 Bn	20.19 Bn
9	Steris	23.21 Bn	22.73 Bn	684.20 Mn	8.29 Bn
10	HeartSciences	7.06 Mn	5.36 Mn	-	-

Download Data